spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioTrinity 2018

23-25 April 2018
Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTO’s and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies.

Each year we seek to improve and evolve the format of the conference in-line with industry trends and to meet the changing demands of our delegates, with key highlights including:

·        Over 2,000 private partnering meetings supported by the partneringONE™ booking system

·        Innovative and insightful programme of keynote presentations, panel discussions and round table debates exploring the latest hot topics in the industry

·        BioLaunchPad™ - a single track series of Company Showcase presentations, all in one room, with an audience capacity of up to 200

·        An improved environment in the partnering area including additional lounge areas and branded coffee stands

·        Refined programme of networking events to further support collaboration and partnership opportunities between delegates.

Our theme for BioTrinity 2018 is ‘Next Generation Healthcare’ which we will explore via a range of insightful keynote and panel discussions including ‘AI and Drug Discovery’, ‘An insight into Nanotechnology’, ‘Next Generation Chemistry’ and ‘Fintech and the Future of the Investment Industry’ – more updates on speakers and topics will follow soon.

A general delegate ticket includes access to the whole conference, including the use of the partneringONE™ meeting scheduler, access to keynote and panel discussions, BioLaunchPad™ company showcase presentations, all social networking events and full catering throughout the conference.
Special rates are available to OBN Members, who can save up to £300 per delegate. Please contact our Membership Manager (Nicola Westgate – nicola.westgate@obn.org.uk) to find out if you are eligible for a member rate or to enquire about becoming an OBN Member. Please note that ticket prices increase in the run-up to the event – the earlier you book, the more money you save!

Please visit www.biotrinity.comfor up to date information.

Organiser contact details:

OBN Events Team
events@obn.org.uk

 
Print this page
Send to a friend
   
spacer
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>


News and Press Releases

ERT Offers First Patient-Administered ECG Assessment for Continuation of Clinical Trials during COVID-19

ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a first-of-its-kind partnership with AliveCor, the leader in AI-based, personal ECG technology. The partnership enables ERT to capture digital cardiac safety data with KardiaMobile 6L, the only FDA-cleared personal ECG for patient-administered 6-lead data collection.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement